Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL828432 | 1.00 | HIF1A (0.44) | HIF1ATSHRCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL25603522 | 0.90 | HIF1A (0.43) | HIF1AGAATP53LMNARAB9A | |
| SCHEMBL23971865 | 0.87 | HIF1A (0.35) | HIF1ATSHRCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL23972133 | 0.86 | HIF1A (0.48) | HIF1ALMNARAB9A | |
| SCHEMBL12548819 | 0.86 | HIF1A (0.56) | HIF1APOLBLMNARAB9A | |
| SCHEMBL23979245 | 0.85 | HIF1A (0.44) | HIF1ALMNARAB9A | |
| SCHEMBL7500240 | 0.83 | HIF1A (0.40) | HIF1AGAATP53LMNARAB9A | |
| SCHEMBL23971955 | 0.83 | HIF1A (0.44) | HIF1ARAB9A | |
| SCHEMBL23971823 | 0.83 | HIF1A (0.53) | HIF1APOLBLMNARAB9A | |
| SCHEMBL22326129 | 0.82 | HIF1A (0.49) | HIF1APOLBLMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030040540-A1 | For use as biocides for protecting plants and industrial materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040540-A1 | For use as biocides for protecting plants and industrial materials | BROX, GPX1, PRDX3 | HIF1A 2185/4885TSHR 4396/4885CYP3A4 1355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.